Your Location:
Home >
Browse articles >
Mechanism of Dahuang Zhechongwan in Treating Myocardial Fibrosis of Rats via TGF-β 1/Smads/miR29 Pathway
Mechanism of Dahuang Zhechongwan in Treating Myocardial Fibrosis of Rats via TGF-
β 1/Smads/miR29 Pathway- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 14, Pages: 21-29(2023)
DOI: 10.13422/j.cnki.syfjx.20230737
Scan QR Code
Full Text(HTML)
Figs( 2 ) Tabs( 8 )
References
Publication Info
Metrics
219
Views
114
Downloads
7
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Molecular Mechanism Analysis of Dengzhan Shengmai Capsules Against Myocardial Fibrosis After Myocardial Infarction Based on Network Robustness Algorithm
Mechanism of Action of Shengmai San-type Formulas in Treatment of Chronic Heart Failure Based on Yin-Yang Theory
Exploring Biological Characteristics of Rat Model of Atrial Fibrillation with Phlegm-heat and Blood Stasis Pattern Based on Metabolomics
Ershen Zhenwu Decoction Treats Chronic Heart Failure by Regulating miR-423-5p/Smad7/TGF-β1/Smads Axis and Myocardial Fibrosis Indicators
Shenfu Injection Improve Chronic Heart Failure by Regulates Glycolytic Pathway Mediated by HIF-1α/PFKFB3 Pathway
Related Author
OU Feifei
ZHANG Bo
PAN Fuzhu
WEI Junying
WU Hongwei
XIAN Minghua
XU Jing
ZHANG Yubin
Related Institution
Panzhou TCM Hospital
School of Pharmacy, Zunyi Medical University
Institute of TCM Health Industry,China Academy of Chinese Medical Sciences
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
School of Traditional Chinese Medicine(TCM), Guangdong Pharmaceutical University


